Fresenius Kabi USA, LLC FDA Inspection Record
Fresenius Kabi USA, LLC is an FDA-registered facility (FEI 3001833549) located in Grand Island, NY, US. Registered operations: ANALYSIS; MANUFACTURE. RegDataLab tracks 14 FDA inspections and 1 compliance action at this facility.
What FDA found at this site
- Latest inspection
- Oct 13, 2023: Voluntary Action Indicated (VAI)
- Inspections on record
- 14 (2 OAI, 9 VAI, 3 NAI)
- Last OAI inspection
- Jan 11, 2013
- Warning letters
- 1 listed by FDA for this FEI, latest Feb 22, 2012
- Form 483 and inspection documents
- 2 in FDA's reading room
- Recalls as the recalling firm
- 3, latest May 22, 2019
Inspections and what FDA cited
| Date | Result | What FDA cited |
|---|---|---|
| Oct 13, 2023 | Voluntary Action Indicated (VAI) | Procedures for sterile drug products (21 CFR 211.113(b)) Investigations of discrepancies, failures (21 CFR 211.192) |
| Aug 30, 2023 | Voluntary Action Indicated (VAI) | Lack of or inadequate procedures (21 CFR 820.100(a)) |
| Aug 12, 2019 | Voluntary Action Indicated (VAI) | No citations listed |
| Mar 30, 2017 | No Action Indicated (NAI) | No citations listed |
| Feb 1, 2017 | Voluntary Action Indicated (VAI) | No citations listed |
| Feb 4, 2016 | Voluntary Action Indicated (VAI) | Procedures not in writing, fully followed (21 CFR 211.22(d)) Training , Education , Experience overall (21 CFR 211.25(a)) Quality control unit review of records (21 CFR 211.192) Investigations of discrepancies, failures (21 CFR 211.192) and 1 more |
| Oct 24, 2014 | Voluntary Action Indicated (VAI) | Buildings of Suitable Size, Construction, Location (21 CFR 211.42(a)) Representative Samples Criteria (21 CFR 211.84(b)) Investigations of discrepancies, failures (21 CFR 211.192) |
| Jan 11, 2013 | Official Action Indicated (OAI) | Procedures not in writing, fully followed (21 CFR 211.22(d)) Written procedures not established/followed (21 CFR 211.67(b)) Procedures for sterile drug products (21 CFR 211.113(b)) Investigations of discrepancies, failures (21 CFR 211.192) and 4 more |
| Aug 29, 2011 | Voluntary Action Indicated (VAI) | No citations listed |
| Jul 8, 2011 | Official Action Indicated (OAI) | No citations listed |
Recalls
| Date | Class | Recall | Product and reason |
|---|---|---|---|
| May 22, 2019 | Class III | D-1386-2019 | Ondansetron Injection, USP, 40 mg / 20 mL, 20 mL vial, Rx Only, Fresenius Kabi USA, LLC… Failed Impurities/Degradation Specifications. |
| Nov 15, 2018 | Class I | D-0298-2019 | SODIUM CHLORIDE INJECTION, USP, 0.9%, 10 mL Single Dose Vial, packaged in a 25-unit tray… and 1 more product Labeling Not Elsewhere Classified: Fresenius Kabi is taking this action due to an incorrect statement on the product insert for product… |
| Jan 22, 2014 | Class II | D-1148-2014 | Heparin Sodium Injection, USP 10,000 USP units per 10 mL (1,000 USP units per mL) For IV… Subpotent; 18 month time point |
Form 483s and inspection documents
FDA record score
13 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.
14 records behind this number
| Record | Date | Points x age weight | Adds |
|---|---|---|---|
| Class I recall D-0298-2019, this FEI as the recalling firm | Nov 15, 2018 | 15 x 0.25 | 3.8 |
| Inspection classified VAI | Oct 13, 2023 | 6 x 0.6 | 3.6 |
| Inspection classified VAI | Aug 30, 2023 | 6 x 0.6 | 3.6 |
| Inspection classified VAI | Aug 12, 2019 | 6 x 0.25 | 1.5 |
| Inspection classified VAI | Feb 1, 2017 | Only the 3 most recent VAI inspections add points | 0 |
| Inspection classified VAI | Feb 4, 2016 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Oct 24, 2014 | 10 years or older, so it adds no points | 0 |
| Class II recall D-1148-2014, this FEI as the recalling firm | Jan 22, 2014 | 10 years or older, so it adds no points | 0 |
| Inspection classified OAI | Jan 11, 2013 | 10 years or older, so it adds no points | 0 |
| Warning letter on FDA's dashboard, which does not show close-outs | Feb 22, 2012 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Aug 29, 2011 | 10 years or older, so it adds no points | 0 |
| Inspection classified OAI | Jul 8, 2011 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Jan 13, 2010 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Sep 17, 2009 | 10 years or older, so it adds no points | 0 |
When each source was last refreshed
| Records | Last refreshed | Source as of | Status |
|---|---|---|---|
| Inspections | Nov 22, 2026 | Newest record Nov 9, 2026 | Current |
| Inspection citations | Nov 22, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions (warning letters, injunctions and other action types) | Nov 22, 2026 | Newest record Nov 13, 2026 | Current |
| Warning letter text | Nov 22, 2026 | Newest record Nov 17, 2026 | Current |
| Recalls (Enforcement Report) | Nov 22, 2026 | Newest record Nov 18, 2026 | Current |
| Form 483s and inspection documents | Nov 18, 2026 | Newest record Nov 17, 2026 | Current |
| Import refusals | Nov 22, 2026 | Newest record Nov 12, 2026 | Current |
Reviewing Fresenius Kabi USA, LLC as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Fresenius Kabi USA, LLC yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Facility details
- Company
- Fresenius Kabi USA, LLC
- Location
- Grand Island, NY (US)
- Registration Expires
- Dec 31, 2027
- Operations
- ANALYSIS; MANUFACTURE
- Source
- decrs